Tradestie Institutional Equity Comparison Engine
EW vs PHG โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EW Overall Edge
EW Captures Institutional Edge (2โ2 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Edwards Lifesciences Corp (EW) driven by superior Growth & Margin, Momentum & Technical while PHG counters with relative strength in Valuation, Options & Structure. Fundamentally, EW trades at 31.6x Forward P/E with 28.8% operating margin (+10.5% YoY revenue) versus PHG at 14.9x Forward P/E and 8.8% operating margin (+2.1% YoY). In options structure, EW sits in UNCLASSIFIED (34th %ile IV; Dealer Gamma Walls on Pro) against PHG sits in SURGE (2nd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
PHG
EW 31.6x vs PHG 14.9x Fwd P/E
Growth & Margin Winner
EW
Op Margin 28.8% vs 8.8% ยท YoY +10.5% vs +2.1%
Momentum & Technical Winner
EW
1Y +23.9% vs +4.5% ยท 52W Pos 96% vs 67%
Options & Structure Winner
PHG
UNCLASSIFIED (34th %ile IV) vs SURGE (2nd %ile IV)
EW
NYSE
Edwards Lifesciences Corp
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$106.66
-0.46% 1D
Market Cap
$60.8B
1M Return
+23.16%
1Y Return
+23.86%
Forward P/E
31.6x
Unified AI Score
31.5 / 100
SELL
Tech 50.0
Fund 29.0
Flow 51.0
Mom 44.0
PHG
NYSE
Koninklijke Philips N.V.
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
$30.21
-0.43% 1D
Market Cap
$29.6B
1M Return
+17.37%
1Y Return
+4.46%
Forward P/E
14.9x
Unified AI Score
28.4 / 100
SELL
Tech 50.0
Fund 23.0
Flow 54.0
Mom 11.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
EW +23.86%
PHG +4.46%
Spread: +19.4 pp (EW Lead)
Pillar 3 Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)
| Period | EW Revenue | PHG Revenue | EW Op. Margin | PHG Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| Q3 '25 | $6.21B | $8.44B | 27.4% | 7.7% | EW |
| Q4 '25 | $6.28B | $10.0B | 23.6% | 11.1% | EW |
| Q1 '26 | $6.59B | $7.66B | 31.2% | 6.2% | EW |
| Q2 '26 | $6.96B | $8.55B | 29.8% | 14.0% | EW |
| Q3 '26 | $6.86B | $8.62B | 30.2% | 3.8% | EW |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EW | PHG | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $60.8B | $29.6B | Larger Scale | EW |
| Trailing P/E Ratio Valuation | 61.5x | 63.2x | Lower Multiple | EW |
| Forward P/E Ratio Valuation | 31.6x | 14.9x | Lower Multiple | PHG |
| Revenue Growth (YoY) Growth | +10.5% | +2.1% | Higher Growth | EW |
| Operating Margin (TTM) Profitability | 28.8% | 8.8% | Higher Margin | EW |
| Net Profit Margin Profitability | 15.3% | 5.4% | Higher Margin | EW |
| Return on Equity (ROE) Capital Efficiency | 9.3% | 8.6% | Higher ROE | EW |
| 52-Week Range Position Momentum | 96% ($75โ$108) | 67% ($24โ$33) | Stronger Trend | EW |
| Beta / 30D Volatility Risk Regime | 0.44ฮฒ ยท 24% Vol | 0.73ฮฒ ยท 38% Vol | Lower Realized Risk | EW |
| Unified Institutional Score Composite Signal | 31.5 / 100 (SELL) | 28.4 / 100 (SELL) | Higher Composite | EW |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full EW vs PHG Buy Guide
EW
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
34th %ile
IV Regime
Balanced (25thโ60th %ile)
PHG
SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
2nd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither EW nor PHG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.